1. Home
  2. NLSP vs REBN Comparison

NLSP vs REBN Comparison

Compare NLSP & REBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NLSP
  • REBN
  • Stock Information
  • Founded
  • NLSP 2015
  • REBN 2015
  • Country
  • NLSP Switzerland
  • REBN United States
  • Employees
  • NLSP N/A
  • REBN N/A
  • Industry
  • NLSP Biotechnology: Pharmaceutical Preparations
  • REBN Restaurants
  • Sector
  • NLSP Health Care
  • REBN Consumer Discretionary
  • Exchange
  • NLSP Nasdaq
  • REBN Nasdaq
  • Market Cap
  • NLSP 12.4M
  • REBN 15.3M
  • IPO Year
  • NLSP 2021
  • REBN 2022
  • Fundamental
  • Price
  • NLSP $2.17
  • REBN $2.50
  • Analyst Decision
  • NLSP
  • REBN
  • Analyst Count
  • NLSP 0
  • REBN 0
  • Target Price
  • NLSP N/A
  • REBN N/A
  • AVG Volume (30 Days)
  • NLSP 193.8K
  • REBN 81.4K
  • Earning Date
  • NLSP 10-17-2025
  • REBN 08-14-2025
  • Dividend Yield
  • NLSP N/A
  • REBN N/A
  • EPS Growth
  • NLSP N/A
  • REBN N/A
  • EPS
  • NLSP N/A
  • REBN N/A
  • Revenue
  • NLSP N/A
  • REBN $6,565,623.00
  • Revenue This Year
  • NLSP N/A
  • REBN $335.98
  • Revenue Next Year
  • NLSP N/A
  • REBN N/A
  • P/E Ratio
  • NLSP N/A
  • REBN N/A
  • Revenue Growth
  • NLSP N/A
  • REBN 14.03
  • 52 Week Low
  • NLSP $1.30
  • REBN $1.03
  • 52 Week High
  • NLSP $6.97
  • REBN $8.30
  • Technical
  • Relative Strength Index (RSI)
  • NLSP 49.77
  • REBN 41.80
  • Support Level
  • NLSP $1.88
  • REBN $2.33
  • Resistance Level
  • NLSP $2.02
  • REBN $2.70
  • Average True Range (ATR)
  • NLSP 0.13
  • REBN 0.17
  • MACD
  • NLSP -0.01
  • REBN -0.03
  • Stochastic Oscillator
  • NLSP 55.77
  • REBN 25.00

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd a clinical-stage biopharmaceutical company focused on the discovery and development of inventive therapies for patients with rare and complex CNS disorders with unmet medical needs. Its compound, mazindol, a triple monoamine reuptake inhibitor and partial orexin receptor 2 agonist, in a proprietary ER formulation, is being developed for the treatment of narcolepsy, IH (follow-on indication), and potentially ADHD (back-up indication). Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

About REBN Reborn Coffee Inc.

Reborn Coffee Inc is an operator and franchisor of retail locations and kiosks that focus on serving specialty-roasted coffee. It is an company that strives for constant improvement in the coffee experience through exploration of new technology and premier service, guided by traditional brewing techniques. The company operates in one reportable segment, consisting of both the wholesale and retail sales of coffee, water, and other beverages.

Share on Social Networks: